Productive escalation of the RBD antigen of the Soberana02 vaccine candidate
Tuesday, March 2, 2021
Author: Sonia Ponce de León
Source: Google Translator
External Source: NP
The General Director of our Center, Eduardo Ojito Magaz, explained to the press the capacities and productive potential of the CIM that have allowed the release of the 340 thousand doses of the Soberana02 vaccine candidate that will begin the phase III clinical trial in March.
<br />Our Director of the Therapeutic Antibodies Plant Danais Alfonso also explained the complexities of the phases of the production process, specifying that the 2nd fermentation campaign of 500L of Soberana02 RBD antigen is already underway.
Comment
Comments
Frequent Questions
How can I access the therapeutic vaccines against lung cancer?
Cuba has 2 therapeutic vaccines for advanced lung cancer:
CIMAvax EGF ® and VAXIRA ® (racotumomab). Both therapeutic vaccines have sanitary registration in the indication of stage III and IV advanced non-small cell lung cancer (NSCLC), after the first line of chemotherapy. The main clinical benefit of these vaccines has been shown to be increased survival and improved quality of life, as well as a broad safety profile.
How to acquire the vaccines?
Foreigners should contact the Cuban Medical Services who will evaluate each case as part of a comprehensive patient care program, with commercial value.
-Cuban Medical Services. Web page:
www.smcsalud.cu.; E-mail: smc@smcsalud.cu
Phone: (537) 209-0977 Fax: (537) 203-1590.
You can also make your request for care expressing the reason for your request, a medical summary and personal data directly to:
International Clinic of the Hermanos Ameijeiras Hospital.
Calle San Lázaro # 701 esq. to Belascoaín, Havana Center, Havana, C.P: 10400, Cuba.
Telephone: (537) 8761029, (537) 8761030, (537) 8761683. Email: turismomedico@hha.sld.cu
International Health Center
La Pradera Calle 15 between 222 A and 234, Siboney neighborhood, Playa Municipality, Havana, Cuba
Telephone: (+537) 273 7467 Ext. 403 (+537) 2737202. Email: comercia@cislapradera.cu